Details for New Drug Application (NDA): 072211
✉ Email this page to a colleague
NDA 072211 describes PANCURONIUM BROMIDE, which is a drug marketed by Dr Reddys, Elkins Sinn, Hospira, and Igi Labs Inc, and is included in eleven NDAs. Additional details are available on the PANCURONIUM BROMIDE profile page.
The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.
The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.
Summary for 072211
| Tradename: | PANCURONIUM BROMIDE |
| Applicant: | Igi Labs Inc |
| Ingredient: | pancuronium bromide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072211
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
| Approval Date: | Mar 31, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
